Current Grants<\/strong><\/p>\n R01 AI083636-01<\/a>\u00a0| (PI: A. Salomon) | 06\/15\/10 to 05\/31\/16 NIH\/NIAID 5P20 GM103421-11<\/a>\u00a0| (PI: B. Ramratnam) | 05\/01\/15 to 04\/30\/20 NIH\/GM 5T32 GM007601-36<\/a>\u00a0| (PI: K. Mowry) | 07\/01\/15 to 06\/30\/20 NIH\/GM Past Grants<\/strong><\/p>\n R01 AI083636-01\u00a0| (PI: A. Salomon) | 6\/1\/11 to 5\/31\/12 | NIH\/NIAID Vertex Pharmaceuticals| (PI: A. Salomon) | 6\/1\/12 to 5\/31\/14 Hyundai Hope on Wheels\u00a0| (PI: R. Altura) | 12\/1\/11-11\/30\/12\u201cIdentification of the phosphoproteome in high and low risk neuroblastoma tumors\u201dThe goal of this proposal is to obtain a phosphoproteomic signature of neuroblastoma tumors.” \u00a0 \u00a0 \u00a0Role: Collaborator<\/p>\n R01 AG024360-06A1<\/a> | (PI: M. Tatar) | 4\/1\/11 to 3\/31\/16 | NIH\/NIA R21 AI083908-02<\/a>\u00a0| (PI: A. Salomon) | 07\/17\/09 to 06\/30\/11 | NIH\/NIAID NIH COBRE grant #2P20RR015578<\/a> | 07\/01\/05 to 02\/28\/10 Beckman Young Investigator Award<\/a> | 09\/01\/06 to 08\/31\/10 NIH R21 grant #1R21DA021765-01<\/a> | 09\/31\/06 to 09\/30\/08 Research Grants Current Grants R01 AI083636-01\u00a0| (PI: A. Salomon) | 06\/15\/10 to 05\/31\/16 NIH\/NIAID “Phosphoproteomic Analysis of T Cell Activation Pathways” The goal of this proposal is the analysis of signaling pathways in human T cells utilizing a combination of novel phosphoproteomic techniques combined with traditional approaches. Role: PI 5P20 GM103421-11\u00a0| (PI: B. Ramratnam) |… Continue Reading Funding<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"","meta":{"footnotes":""},"class_list":["post-251","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.cellpathway.com\/index.php?rest_route=\/wp\/v2\/pages\/251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cellpathway.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cellpathway.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cellpathway.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cellpathway.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=251"}],"version-history":[{"count":43,"href":"https:\/\/www.cellpathway.com\/index.php?rest_route=\/wp\/v2\/pages\/251\/revisions"}],"predecessor-version":[{"id":735,"href":"https:\/\/www.cellpathway.com\/index.php?rest_route=\/wp\/v2\/pages\/251\/revisions\/735"}],"wp:attachment":[{"href":"https:\/\/www.cellpathway.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n“Phosphoproteomic Analysis of T Cell Activation Pathways”<\/em>
\nThe goal of this proposal is the analysis of signaling pathways in human T cells utilizing a combination of novel phosphoproteomic techniques combined with traditional approaches.
\nRole: PI<\/p>\n
\n“COBRE Center for Cancer Research Development”<\/em>
\nCCRD will promote the expansion of basic cancer research by creating a supportive research environment that facilitates the transition of promising scientists into independent investigators.
\nRole: Subcontract PI,\u00a0Director of Proteomic Core Facility<\/p>\n
\n“Training in Molecular and Cell Biology andBiochemistry”<\/em>
\nThis competing renewal application requests continuation of support for years 36-40 for training in Molecular and Cell Biology and Biochemistry for an exceptional cohort of predoctoral students in the Brown University Graduate Program in Molecular Biology, Cell Biology and Biochemistry (MCB)
\nRole:\u00a0Co-PI<\/p>\n
\n“Phosphoproteomic Analysis of T Cell Activation Pathways”<\/em>
\nThis R01 supplement provides direct cost for user fees for the Salomon lab on the Orbitrap VELOS mass spectrometer in the EPSCoR Proteomic Core Facility.
\nRole: PI<\/p>\n
\n“Quantitative phosphoproteomic dissection of bidirectional signaling pathways”<\/em>
\nThis R01 supplement provides $37,908 direct cost for user fees for the Salomon lab on the Orbitrap VELOS mass spectrometer in the EPSCoR Proteomic Core Facility.
\nRole: PI<\/p>\n
\n“Functions and Interactions of DFOXO in Drosophila Aging”<\/em>
\nThe work proposed in this renewal aims to understand how the several\u00a0different insulin like proteins of Drosophila work to regulate aging and alternatively, metabolism.
\nRole: Collaborator<\/p>\n
\n“Towards a Molecular Signature of Neutrophil Priming”<\/em>
\nThe goal of this proposal is the analysis of signaling pathways in human neutrophil priming utilizing novel phosphoproteomic techniques developed in our lab.<\/p>\n
\n“Center for Cancer Signaling Networks”<\/em> Dr. John Sedivy PI
\nProgram Project 3: “High-throughput Proteomic Analysis of Signaling Pathways”<\/p>\n
\n“Phosphoproteomic analysis of cellular signaling pathways in allergy and asthma”<\/em>
\nTotal direct costs to Salomon lab 266,000$ over 4 years<\/p>\n
\n“The Neuronal Nicotinic Acetylcholine Receptor Interactome via a Knock-In Mouse”<\/em> (PI:Hawrot)<\/p>\n","protected":false},"excerpt":{"rendered":"